Janssen R&D
Lower Gwynedd Township/Spring House, PA, United States
Associate Director Immunology Discovery Janssen R&D LLC
0004: CD22 X CD79b Bispecific Ab Potently Inhibits B Cell Activation and Plasmablast Accumulation
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure information not submitted.